OXURIONOXURIONOXURION

OXURION

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪901.48 K‬EUR
−0.0224EUR
‪−18.97 M‬EUR
‪263.00 K‬EUR
‪7.56 B‬
Beta (1Y)
3.64

About OXURION

CEO
Ghoson Pascal
Headquarters
Leuven
Employees (FY)
19
Founded
2006
ISIN
BE0003846632
FIGI
BBG000L0P7W7
Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OXUR is 0.0001 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange OXURION stocks are traded under the ticker OXUR.
OXURION is going to release the next earnings report on Sep 30, 2024. Keep track of upcoming events with our Earnings Calendar.
OXUR stock is 0% volatile and has beta coefficient of 3.64. Check out the list of the most volatile stocks — is OXURION there?
OXUR earnings for the last quarter are −0.35 EUR per share, whereas the estimation was −0.42 EUR resulting in a 16.67% surprise. The estimated earnings for the next quarter are −0.39 EUR per share. See more details about OXURION earnings.
Yes, you can track OXURION financials in yearly and quarterly reports right on TradingView.
OXUR stock hasn't changed in a week, the last month showed zero change in price, over the last year OXURION has showed a 98.18% decrease.
OXUR net income for the last quarter is ‪−8.35 M‬ EUR, while the quarter before that showed ‪−10.62 M‬ EUR of net income which accounts for 21.43% change. Track more OXURION financial stats to get the full picture.
No, OXUR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OXUR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OXURION stock right from TradingView charts — choose your broker and connect to your account.
OXUR reached its all-time high on Aug 27, 2013 with the price of 29.7000 EUR, and its all-time low was 0.0001 EUR and was reached on Mar 7, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 19.00 employees. See our rating of the largest employees — is OXURION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OXURION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OXURION stock shows the sell signal. See more of OXURION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OXURION EBITDA is ‪−13.46 M‬ EUR, and current EBITDA margin is ‪−5.12 K‬%. See more stats in OXURION financial statements.